Yuki Sugo
Papers
1
Total Citations
8
H-Index
1
About
Yuki Sugo is a clinical anesthesiologist and researcher whose work focuses on the intersection of anesthetic pharmacology and cancer outcomes. His primary research area is perioperative immunomodulation, particularly how anesthetic techniques can influence the immune system during cancer surgery. Sugo’s most notable contribution is a randomized pilot trial investigating the use of ketamine as an adjunct to total intravenous anesthesia in patients undergoing minimally invasive radical prostatectomy. This study, which has garnered 8 citations, demonstrated that ketamine may help preserve natural killer cell cytotoxicity (NKCC), a critical immune function often suppressed after surgery and linked to poorer oncologic outcomes. By exploring how anesthetic agents can directly modulate immune responses, Sugo’s work addresses a pressing question in perioperative medicine: whether the choice of anesthesia can improve long-term cancer prognosis. His research is especially relevant for clinicians and researchers interested in the immunologic consequences of surgery and the potential for anesthetic techniques to serve as therapeutic interventions. Through this focused line of inquiry, Sugo contributes to a growing body of evidence that anesthesiology may play a pivotal role in cancer care beyond the operating room.
Research Focus
Key Achievements
Top Papers
- 1